<DOC>
	<DOCNO>NCT00002287</DOCNO>
	<brief_summary>To evaluate safety effectiveness Retrovir ( AZT ) use prophylaxis health care worker risk HIV infection exposure HIV-contaminated blood blood component .</brief_summary>
	<brief_title>A Study Retrovir Prevention HIV Infection Health Care Workers Accidentally Exposed Virus</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<criteria>Exclusion Criteria Coexisting Condition : Patients follow exclude : A prior history malignancy cutaneous basal cell cervical carcinoma . Other significant , chronic underlie medical illness , physician 's judgment , would impair study completion . Evidence compromise bone marrow function ( lab result ) blood transfusion within last month . Liver dysfunction indicate lab result . Patients exclude prior diagnosis HIV infection one follow criterion : HIV antibody positive ELISA Western blot assay certify test method . ( Patients ELISA positive Western blot confirmatory test negative may continue study ) . HIV antigen positive . Clinical symptom lead diagnosis license physician AIDS AIDS relate complex AIDSrelated dementia . Also exclude individual experience similar HIV exposure describe protocol past month individual previously enrol study . The purpose exclusion eliminate possible seroconversion individual could attribute HIV exposure single exposure experience prior entry study . Prior Medication : Excluded within 4 week study entry : Any potentially myelosuppressive drug . Nephrotoxic agent . Other experimental therapy . Exposure health care worker HIVcontaminated blood blood component within 5 day prior begin therapy , define one following : Penetrating wound needle recently remove patient sample container ( e.g. , blood bag , blood tube ) sharp object visibly contaminate HIVpositive blood blood component . In case needlesticks cut sharp object , blood blood component must expose air 1 hour . If actual infusion blood occurs , 1hour time limit apply . Hypodermic needle come contact blood blood component HIV source need visibly contaminate blood consider source contamination . Significant exposure HIVpositive blood blood component result splash abrade skin . Significant exposure HIVpositive blood blood component result splash mucous membrane . Participant must able give informed consent . Active drug alcohol abuse sufficient physician 's opinion prevent compliance study regimen .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 1989</verification_date>
	<keyword>Health Manpower</keyword>
	<keyword>Accidents , Occupational</keyword>
	<keyword>Zidovudine</keyword>
</DOC>